Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > News > My Top Four Emerging Micro-Cap Biotech Stocks

November 19th, 2007

My Top Four Emerging Micro-Cap Biotech Stocks

Abstract:
BioSante Pharma (BPAX) recently began trading on the Nasdaq under a new ticker in early November and the Company has recently achieved clarity from the FDA on the clinical development requirements for its low-dose testosterone transdermal gel treatment candidate for female sexual dysfunction called LibiGel. BioSante expects to launch a Phase 3 safety trial before year-end and also plans to conduct a second Phase 3 efficacy trial in early 2008. The cardiovascular safety study will involve 2,400 to 3,100 women with one year results sufficient to support a NDA filing (with a four year follow-up also required) for LibiGel along with the two Phase 3 efficacy studies, which will be shorter in duration and involve fewer women. Other recent events include the acquisition of Bradley Pharma (BDY) by privately held Nycomed. Bradley currently markets BioSante's lowest-approved dose transdermal estradiol gel for the treatment of hot flashes and the Nycomed acquisition could boost sales of Elestrin as part of a bigger company with a larger marketing budget. Finally, BioSante anticipates a licensing deal by year-end for its CaP nanotechnology in the area of cosmetic medicine as a dermal filler for the treatment of wrinkles and other applications.

Source:
seekingalpha.com

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Investments/IPO's/Splits

Harris & Harris Group Issues Letter to Shareholders and Information for Shareholder Call on Tuesday, November 15, 2016 November 14th, 2016

Harris & Harris Group Issues Business Update and Reports Financial Statements as of September 30, 2016 November 9th, 2016

Forge Nano raises $20 million in Series A Funding: Nano coating technology innovator Forge Nano will use funding to expand manufacturing capacity and grow Lithium-Ion battery opportunities November 3rd, 2016

Harris & Harris Group Notes Announcements by Its Portfolio Companies During the Third Quarter of 2016 September 30th, 2016

Nanomedicine

UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016

Nanobiotix Provides Update on Global Development of Lead Product NBTXR3: Seven clinical trials across the world: More than 2/3 of STS patients recruited in the “act.in.sarc” Phase II/III trial: Phase I/II prostate cancer trial now recruiting in the U.S. November 28th, 2016

From champagne bubbles, dance parties and disease to new nanomaterials: Understanding nucleation of protein filaments might help with Alzheimer's Disease and type 2 Diabetes November 24th, 2016

Nanopolymer-modified protein array can pinpoint hard-to-find cancer biomarker November 17th, 2016

Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers

UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016

Deep insights from surface reactions: Researchers use Stampede supercomputer to study new chemical sensing methods, desalination and bacterial energy production December 2nd, 2016

Quantum obstacle course changes material from superconductor to insulator December 1st, 2016

Throwing new light on printed organic solar cells December 1st, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project